These guidelines publish the regulatory requirements for authorizing the emergency use of a Medical Product (Allopathic Medicines, Biological Medicinal Products and Medical Devices) during a declared public health emergency. Such emergencies shall include, but not limited to, a heightened risk of affliction or attack on the life, health, safety and security of the general public or any incident with a significant potential to affect national security.
